What is PRALUENT® (alirocumab)?
PRALUENT is an injectable prescription medicine used:
- in adults with cardiovascular disease to reduce the risk of heart attack, stroke, and certain types of chest pain conditions (unstable angina) requiring hospitalization.
- along with diet, alone or together with other cholesterol-lowering medicines in adults with high blood cholesterol levels called primary hyperlipidemia (including a type of high cholesterol called heterozygous familial hypercholesterolemia), to reduce low-density lipoprotein cholesterol (LDL-C) or bad cholesterol.
It is not known if PRALUENT is safe and effective in children.
Important Safety Information
Do not use PRALUENT if you are allergic to alirocumab or to any of the ingredients in PRALUENT.
Before you start using PRALUENT, tell your healthcare provider about all your medical conditions, including
allergies, and if you are pregnant or plan to become pregnant or if you are breastfeeding or
plan to breastfeed.
Tell your healthcare provider or pharmacist about any prescription and over-the-counter medicines you
are taking or plan to take, including natural or herbal remedies.
PRALUENT can cause serious side effects, including allergic reactions that can be severe and require
treatment in a hospital. Call your healthcare provider or go to the nearest hospital emergency room
right away if you have any symptoms of an allergic reaction including a severe rash, redness,
severe itching, a swollen face, or trouble breathing.
The most common side effects of PRALUENT include: redness, itching, swelling, or pain/tenderness at
the injection site, symptoms of the common cold, and flu or flu-like symptoms. Tell your
healthcare provider if you have any side effect that bothers you or that does not go away.
Talk to your doctor about the right way to prepare and give yourself a PRALUENT injection
and follow the "Instructions for Use" that comes with PRALUENT.
You may report side effects to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
for Full Prescribing
Information for PRALUENT.
to learn more about Sanofi's commitment to fighting counterfeit drugs.